Brief: Intelligent Bio Updates FDA 510(k) Progress for Fingerprint Drug Test System, Highlights Accuracy & Readiness
17/09/2025 13:47
Sept 17 (Reuters) - Intelligent Bio Solutions Inc INBS.O: INTELLIGENT BIO SOLUTIONS PROVIDES UPDATE ON FDA 510(K) CLEARANCE PROCESS FOR INTELLIGENT FINGERPRINTING DRUG SCREENING SYSTEM INTELLIGENT BIO SOLUTIONS - FDA REQUESTS NEW ADDITIONAL INFORMATION THAT REQUIRES CO TO RESUBMIT NEW 510(K) NOTIFICATION INTELLIGENT BIO SOLUTIONS - EXPECTS INVESTOR UPDATE IN TEN DAYS OUTLINING UPDATED TIMELINE FOR FDA CLEARANCE Source text: ID:nGNX1DCBwL Further company coverage: INBS.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Intelligent Bio Solutions
See all newsBrief: Intelligent Bio Solutions Reports Fiscal 2026 Full-Year Revenue Growth Of 38% Year-Over-Year, Driven By Reader Installed Base And High-Margin Cartridge Growth
Brief: Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance And Planned US Market Entry
Intelligent Bio Solutions Q3 revenue rises 46%, gross margin tops 50%
Intelligent Bio Solutions rise after clearing security tests ahead of FDA filing
Brief: Intelligent Bio Solutions Completes Clinical Cut-Off Study